Conduit Pharmaceuticals advances its pipeline with key progress in preclinical lupus studies for AZD5658, Phase IIa trial design for AZD1656, ...

Conduit Pharmaceuticals has made significant advancements in its pipeline, particularly in preclinical studies for its drug AZD5658 and the design of a Phase IIa clinical trial for AZD1656 ...

Conduit Pharmaceuticals Inc. (Nasdaq: CDT) ('Conduit Pharmaceuticals' or 'Conduit' or the 'Company”) announces that, on February 11, 2025, the Company presented its plan of compliance to The Nasdaq ...

A crucial aspect of these legislative changes is the impact on trusts named as beneficiaries of retirement accounts. This ...

STAYING IN SHAPE is a continuous process. If you've ever had to press pause on your routine, changed up your lifestyle, moved ...

The Rochester City Council will be asked on Monday to approve tax-exempt bonds with Mayo Clinic responsible for costs and ...

Conduit Pharmaceuticals Inc., currently valued ... a hearing with the Nasdaq Hearing Panel to present its compliance plan, delaying any delisting action until a decision is made.

The UK and Scottish governments have unveiled options to secure an industrial future for Petroineos' soon-to-be-shuttered 150 ...

Despite these efforts, Conduit is still facing potential delisting due to non-compliance with Nasdaq’s market value requirements. The company has requested a hearing with the Nasdaq Hearing Panel to ...

BP has struck a $1-billion deal to sell 25% of its stake in a pipeline taking gas from Azerbaijan to Turkey to New ...

A new £1.5m study outlines nine long-term industrial options for Grangemouth, requiring £3.5bn in private investment. The projects could ...

Corning (GLW) boosts Q1 sales guidance, unveils AI-driven fiber solutions, and projects $2.5B solar revenue by 2028.